Brief: Orbimed Advisors LLC Reports 13.1% Stake In Kinnate Biopharma As Of April 28 - SEC Filing
03/05/2023 12:36
May 3 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* ORBIMED ADVISORS LLC REPORTS 13.1% STAKE IN KINNATE
BIOPHARMA AS
OF APRIL 28 - SEC FILING
Source text for Eikon: ID:
Further company coverage: KNTE.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview